Abcam Founder to Push for Better Performance at Biotech Firm (2)

May 2, 2023, 6:36 AM UTC

Abcam Plc founder Jonathan Milner is pushing for better performance at the biotechnology supplier he started 25 years ago.

The British scientist and entrepreneur aims to take a more active role in influencing Abcam’s governance, performance and direction, according to a filing Monday, which confirmed an earlier Bloomberg News report.

He’s already held several discussions with the company and has been seeking a board seat, according to a person familiar with the matter, who asked not to be identified because the information is private.

Milner is one of Cambridge, England-based Abcam’s largest investors with a stake of about 6.4%, ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.